← Evidence map

ReviewBMJ global health2025

The role of the right valuation method in setting the firm's break-even price for mpox (and other) vaccines.

Peter-Jan Engelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40441743